# Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948

> **NCT06691828** · PHASE1 · COMPLETED · sponsor: **Nurix Therapeutics, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** NX-5948

## Key facts

- **NCT ID:** NCT06691828
- **Lead sponsor:** Nurix Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2024-11-28
- **Final completion:** 2024-12-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06691828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06691828, "Absolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06691828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*